Final-Program-ATS-2023-AP.vp

208

MONDAY • MAY 22

803 Clinical Features of Patients With an Eosinophilic Phenotype: An Analysis of the U.S Bronchiectasis and NTM Research Registry/ D.J. Maselli, San Antonio, TX 804 Association of Baseline and Subsequent Bronchiectasis Exacerbations in Patients From the US Bronchiectasis and NTM Research Registry (BRR)/ T.R. Aksamit, Rochester, MN 805 Longitudinal Changes in Forced Expiratory Volume 1 (FEV1) According to Exacerbation Frequency in Patients From the US Bronchiectasis and NTM Research Registry (BRR)/ N. Lapinel, New Orleans, LA 806 Exercise Capacity as a Predictor of 3-year Mortality in Adult Bronchiectasis Patients/ S.Z. Rached, Sao Paulo, Brazil 807 The Dipeptidyl Peptidase-1 Inhibitor Brensocatib Reduces Airway Azurocidin-1 Levels in Bronchiectasis/ E. Johnson, Dundee, United Kingdom 808 Outcomes of Patients With Bronchiectasis by Disease Severity: Subgroup Analysis From the Brensocatib WILLOW Study/ M.L. Metersky, Farmington, CT 809 Treatment Patterns and Adverse Events (AEs) Among Patients With Bronchiectasis (BE) Chronically Receiving Macrolides Over a 1-year Follow-up Period/ A.F. Barker, Portland, OR 810 Clinical Cluster Analysis of Bronchiectasis-chronic Obstructive Pulmonary Diseases Overlap Syndrome (BCOS); Real World Evidence From a Developing Country/ N. Bhatta, Dharan, Nepal 811 Origin of Sputum Elasticity/ L. Esteban Enjuto, Gières, France 812 Evaluation of Procedures for Obtaining Cilia and Quantitative Parameters of Ciliary Beat Obtained by Nasal Brushing for the Diagnosis of Primary Ciliary Dyskinesia/ T. Kido, Nagasaki, Japan 813 Diagnostic Confirmation Bias Delaying Cystic Fibrosis Diagnosis And Infertility Treatment/ R. Zhang, Portland, OR 814 CFTR Modulator Therapy For N1303K Mutations/ P. Barletta, Miami, FL 815 Severe Hypernatremia Due to Polyethylene Glycol-Electrolyte Ascorbic Acid Nasogastric Lavage Treatment in a Cystic Fibrosis Patient With Distal Intestinal Obstruction Syndrome/ M. Eliliwi, Omaha, NE 816 An Unusual Cause Of Dyspnea In A Cystic Fibrosis Patient/ S. Mcintyre, Nashville, TN 817 Transitions of Care Outcomes in Cystic Fibrosis at a Single Center/ S. Mcintyre, Nashville, TN 818 Risk Factors for Increased 1-year Mortality in Cystic Fibrosis Patients Underwent Combined Lung-liver Transplantation in Post LAS Era/ J. Gatuz, Shreveport, LA

918 Reflecting on Reflection Rounds: Discovering and Analyzing Elements of an ICU Team Group Discussion That Improve Provider Wellness/ I.R. Krumm, San Francisco, CA 919 Implementation of a Short “On- Demand” Feedback Form for Fellows in the Medical Intensive Care Unit/ G. Schroeder, St. Louis, MO 920 The Pipeline Is Running Dry: Survey Results From the Current Pool of Sarcoidosis Researchers and Clinicians/ N. Arger, San Francisco, CA 921 A Novel Ambulatory Curriculum for Pulmonary and Critical Care Fellows Utilizing Adult Learning Theory and Multi-disciplinary Teachers/ K. Mcavoy, New Haven, CT 922 Swipe for Success: A Novel Platform for the Humble Fellowship Manual/ J. Alunilkummannil, Cleveland, OH 923 A Qualitative Study of Provider Perspectives on Cognitive Load During Intensive Care Unit Rounds/ N. Held, Aurora, CO 924 Post-interview Communication Practices Among Critical Care Medicine/Pulmonary and Critical Care Medicine Fellowship Applicants and Program Directors and Impact on Rank Lists/ M. John, Seattle, WA 925 Fellowship Applicant Perceptions and Preferences on Virtual Versus In-Person Interview Formats/ L. Moore, Cleveland, OH

CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

B103 HOT TOPICS IN CYSTIC FIBROSIS, BRONCHIECTASIS, AND BREATHLESSNESS 2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Room 209 A-C (Level 2)

Poster Viewing

2:15-3:00 3:00-4:15

Discussion

Chairing: J.L. Taylor-Cousar, MD, MSc, ATSF, Denver, CO P. Krishnan, MD, Shreveport, LA K. Montemayor, MD, Baltimore, MD 801 Biologic Therapy Management In Adult Patients With Bronchiectasis And Allergic Bronchopulmonary Aspergillosis: A Case Series/ C. Iskandir, New York, NY 802 The Prevalence and Clinical Features of Eosinophilic Bronchiectasis in a Japanese Population/ N. Fukuda, Yokohama, Japan

ATS 2023 • Washington, DC